Orlando Health Cancer Institute Downtown Orlando is a clinical research site located in Orlando, Florida, United States 32806.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Orlando Health Cancer Institute Downtown Orlando has participated in 5 clinical trials with 4 currently active.
Therapeutic areas: Platinum-resistant Ovarian Cancer, Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma.
Sponsors: Genmab, BeOne Medicines, Incyte Corporation.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Florida · View every site in Orlando
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Orlando Health Cancer Institute Downtown Orlando has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Orlando Health Cancer Institute Downtown Orlando has 5 clinical trials on record, with 4 currently active. Their work covers Platinum-resistant Ovarian Cancer, Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma.
Orlando Health Cancer Institute Downtown Orlando has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.